NM_198428.3:c.310delT
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 16P and 1B. PVS1PP5_Very_StrongBS2_Supporting
The NM_198428.3(BBS9):c.310delT(p.Cys104ValfsTer20) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000366 in 1,584,562 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. C104C) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_198428.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- Bardet-Biedl syndrome 9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BBS9 | NM_198428.3 | c.310delT | p.Cys104ValfsTer20 | frameshift_variant | Exon 4 of 23 | ENST00000242067.11 | NP_940820.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000225 AC: 34AN: 151028Hom.: 2 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.0000725 AC: 18AN: 248184 AF XY: 0.0000596 show subpopulations
GnomAD4 exome AF: 0.0000167 AC: 24AN: 1433534Hom.: 0 Cov.: 28 AF XY: 0.0000168 AC XY: 12AN XY: 714442 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000225 AC: 34AN: 151028Hom.: 2 Cov.: 30 AF XY: 0.000326 AC XY: 24AN XY: 73656 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 9 Pathogenic:3
- -
- -
- -
BBS9-related disorder Pathogenic:1
The BBS9 c.310delT variant is predicted to result in a frameshift and premature protein termination (p.Cys104Valfs*20). The c.310del variant has been reported, along with a variant of uncertain significance, in a teenage patient with obesity (Supplementary Table 3, Kleinendorst et al. 2018. PubMed ID: 29970488). This variant was also reported with another BBS9 frameshift variant in a patient with Bardet-Biedl syndrome (reported as c.175del, p.C59fs*20 using the alternative transcript NM_001348042 in K131 in Zacchia et al. 2021. PubMed ID: 33964006). This variant is reported in 0.051% of alleles in individuals of Latino descent in gnomAD. Frameshift variants in BBS9 are expected to be pathogenic for autosomal recessive Bardet-Biedl syndrome (Khan et al. 2016. PubMed ID: 26846096; Supplementary Table 3, Shaheen et al. 2016. PubMed ID: 27894351; OMIM: #615986). This variant is interpreted as likely pathogenic. -
Bardet-Biedl syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Cys104Valfs*20) in the BBS9 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BBS9 are known to be pathogenic (PMID: 16380913, 20177705). This variant is present in population databases (rs777498165, gnomAD 0.05%). This premature translational stop signal has been observed in individual(s) with obesity (PMID: 29970488). ClinVar contains an entry for this variant (Variation ID: 462970). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at